Evidence map›Paper›PMID 39529575›Full record

ReviewEmerging microbes & infections2024

Unbiased phage display screening identifies hidden malaria vaccine targets.

Marcelo Jacobs-Lorena, Sung-Jae Cha

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Emerging microbes & infections, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marcelo Jacobs-LorenaDepartment of Molecular Microbiology and Immunology and Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Sung-Jae ChaDepartment of Medical Sciences, Mercer University School of Medicine, Macon, GA, USA.

Funding

Development of novel malaria pre-erythrocytic vaccine antigens targeting Plasmodium sporozoite liver infectionR21AI166451 · NIAID · MERCER UNIVERSITY MACON · PI CHA, SUNG-JAE · 2023 to 2024
$392k
NIAID NIH HHS R21 AI166451
6 · The paper itself

Abstract

Malaria is among the deadliest infectious diseases. Over 200 million annual clinical malaria cases are reported and more than half a million people, mostly children, die every year. The most advanced RTS,S/AS01 vaccine based on the

Indexed as

Malaria, FalciparumMalaria VaccinesPlasmodium falciparumProtozoan ProteinsAnimalsAntigens, ProtozoanCell Surface Display TechniquesHost-Parasite InteractionsHumansPeptide LibrarySporozoitesVaccine DevelopmentAntigens, Protozoancircumsporozoite protein, ProtozoanMalaria VaccinesPeptide LibraryProtozoan Proteinshost cell receptorMalariaparasite ligandphage displayvaccine target

Identifiers

PMID39529575
PMCPMC11587725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.